Diabetes remission following metabolic surgery: is GLP-1 the culprit? (Q38129779)

29 August 2017

Diabetes remission following metabolic surgery: is GLP-1 the culprit? (English)

1 reference

29 August 2017

Josep Vidal

1

1 reference

PubMed ID

23955665

29 August 2017

Amanda Jiménez

series ordinal

2

1 reference

29 August 2017

1 October 2013

1 reference

Current Atherosclerosis Reports

29 August 2017

1 reference

29 August 2017

15

1 reference

29 August 2017

10

1 reference

29 August 2017

357

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-013-0357-1

29 August 2017

0 references

cites work

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Bariatric surgery versus conventional medical therapy for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Biology of incretins: GLP-1 and GIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Glucagon-like peptide receptor agonists and dipeptidyl peptidase-4 inhibitors in the treatment of diabetes: a review of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Postprandial diabetic glucose tolerance is normalized by gastric bypass feeding as opposed to gastric feeding and is associated with exaggerated GLP-1 secretion: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

GLP-1 response to a mixed meal: what happens 10 years after Roux-en-Y gastric bypass (RYGB)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Effects of sleeve gastrectomy and medical treatment for obesity on glucagon-like peptide 1 levels and glucose homeostasis in non-diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Gastric bypass and banding equally improve insulin sensitivity and β cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

The role of endogenous incretin secretion as amplifier of glucose-stimulated insulin secretion in healthy subjects and patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Mechanisms linking obesity to insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor-mediated mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

The role of the gut hormone GLP-1 in the metabolic improvements caused by ileal transposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Laparoscopic ileal interposition with diverted sleeve gastrectomy for treatment of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Bariatric surgeries: beyond restriction and malabsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-013-0357-1

Nutrient infusion bypassing duodenum-jejunum improves insulin sensitivity in glucose-tolerant and diabetic obese subjects.

21 January 2018

1 reference

12 December 2020

GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgery

1 reference

12 December 2020

GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects

1 reference

12 December 2020

The Role of β-Cell Function and Insulin Sensitivity in the Remission of Type 2 Diabetes after Gastric Bypass Surgery

1 reference

12 December 2020

Endogenous GLP-1 regulates postprandial glycemia in humans: relative contributions of insulin, glucagon, and gastric emptying

1 reference

12 December 2020

Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.

1 reference

12 December 2020

Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus

1 reference

12 December 2020

Alterations of global gastrointestinal motility after sleeve gastrectomy: a prospective study

1 reference

12 December 2020

Acute peripheral GLP-1 receptor agonism or antagonism does not alter energy expenditure in rats after Roux-en-Y gastric bypass

1 reference

12 December 2020

Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like Peptide 1 receptor deficiency

1 reference

12 December 2020

Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.

1 reference

12 December 2020

Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database

1 reference

12 December 2020

10.1007/S11883-013-0357-1

Identifiers

DOI

1 reference

PubMed ID

23955665

Dimensions Publication ID

29 August 2017

0 references

1 reference

PubMed ID

23955665